Dark

Check out our Dark Pool Levels

AXNX
Axonics, Inc. Common Stock
stock NASDAQ

Inactive

Nov 14, 2024

70.98USD+0.752%(+0.53)4,149,399

Pre-market

0.00USD-100.000%(-70.45)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 7, 2022

01:09PM EST What 4 Analyst Ratings Have To Say About Axonics Benzinga

01:04PM EST Morgan Stanley Maintains Overweight on Axonics, Lowers Price Target to $73 Benzinga

Jan 6, 2022

06:02AM EST Axonics Sees Q4 Sales $52.9M-$53.3M Vs. $49.92M Est., FY21 Sales $180.1M-$180.5M Vs. $177.06M Est. Benzinga

Dec 14, 2021

11:49AM EST Needham Maintains Buy on Axonics, Lowers Price Target to $62 Benzinga

Nov 17, 2021

05:01AM EST Deloitte Unveils 2021 North America Technology Fast 500 Rankings PR Newswire

Nov 5, 2021

12:13PM EDT UPDATE: Needham On Axonics Price Target Cut: Firm Notes Disappointing Results Given EPS Beat But Revenue Miss & Believes 'COVID Surge Was The Primary Culprit'; Sees SNM Growth Slow To 14% With FDA Results Expected In 1H22 For Non-Rechargeable SNM Device Benzinga

09:43AM EDT The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill Benzinga

09:40AM EDT SVB Leerink Maintains Outperform on Axonics, Raises Price Target to $85 Benzinga

09:37AM EDT Needham Maintains Buy on Axonics, Lowers Price Target to $71 Benzinga

09:21AM EDT Axonics Modulation Tech Sees Q4 Sales $49.8M Vs. $57.37M Est., FY21 Sales $177M Vs. $186.31M Est. Benzinga

09:21AM EDT Axonics Modulation Tech Q3 EPS $(0.38) Beats $(0.43) Estimate, Sales $46.90M Miss $48.97M Estimate Benzinga

Nov 4, 2021

08:19AM EDT The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO Benzinga

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 7, 2021

07:00AM EDT Axonics(r) to Report Third Quarter 2021 Financial Results on November 4 Business Wire

Sep 23, 2021

09:59AM EDT US Patent Office Rejects Three More Axonics' Challenge To Medtronic Patents Benzinga

Sep 22, 2021

06:08PM EDT Axonics(r) Provides Additional Update on Inter Partes Review Proceedings Business Wire

Sep 14, 2021

07:50AM EDT The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout Benzinga

Sep 13, 2021

05:30PM EDT U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtronic Patents Benzinga

05:19PM EDT Axonics(r) Announces Partial Decision on Inter Partes Review Proceedings Business Wire

Sep 10, 2021

08:00AM EDT The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test Benzinga

Sep 8, 2021

07:32AM EDT The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod Benzinga

Sep 3, 2021

07:31AM EDT The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 30, 2021

11:09AM EDT Looking into Axonics Modulation Tech's Return on Capital Employed Benzinga

Aug 27, 2021

06:00AM EDT Axonics(r) to Participate in Upcoming Investor Conferences Business Wire

Aug 24, 2021

08:09AM EDT The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal Benzinga

Aug 10, 2021

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 9, 2021

09:38AM EDT Morgan Stanley Maintains Overweight on Axonics, Raises Price Target to $74 Benzinga

Aug 6, 2021

07:38AM EDT Barclays Maintains Overweight on Axonics, Raises Price Target to $79 Benzinga

Aug 5, 2021

04:22PM EDT Axonics Modulation Tech Q2 EPS $(0.59) Misses $(0.49) Estimate, Sales $45.90M Beat $39.82M Estimate Benzinga

04:01PM EDT Axonics(r) Reports Second Quarter 2021 Financial Results Business Wire

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

Jul 30, 2021

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

Jul 15, 2021

06:06AM EDT Axonics Appoints Esteban Lpez To Board RTTNews

06:00AM EDT Axonics(r) Announces Appointment of Dr. Esteban Lpez to its Board of Directors Business Wire

Jul 14, 2021

08:12AM EDT BioLife Solutions Says Mike Rice To Succeed Raymond Cohen As Chairman RTTNews

08:05AM EDT BioLife Solutions Announces Changes to Board of Directors PR Newswire

Jul 12, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2021 Benzinga

08:27AM EDT Barclays Initiates Coverage On Axonics with Overweight Rating, Announces Price Target of $74 Benzinga

Jun 29, 2021

08:17AM EDT The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout Benzinga

Jun 28, 2021

11:28AM EDT UPDATE: Needham On Axonics Buy Rating: Firm Cites Completed Submission For Non-Rechargeable SNM System 'To Drive The Next Leg Of Market Share Gains'. Benzinga

05:21AM EDT Needham Maintains Buy on Axonics, Raises Price Target to $78 Benzinga

Jun 25, 2021

07:32AM EDT The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs Benzinga

Jun 24, 2021

04:01PM EDT Axonics Reports Filed Premarket Approval Supplement With FDA For Non-Rechargable Implantable Sacral Neurostimulator Benzinga

04:01PM EDT Axonics(r) Files PMA Supplement with the FDA for Non-Rechargeable Implantable Sacral Neurostimulator Business Wire

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 23, 2021

07:35AM EDT The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

May 20, 2021

06:23AM EDT Axonics Receives FDA Approval Allowing Use Of Detachable Extremity Coils For Patients Undergoing 1.5T And 3.0T MRI Scans RTTNews

06:02AM EDT Axonics Receives FDA Approval Further Expanding MRI Labeling Benzinga

May 18, 2021

09:05AM EDT Axonics Reports CE Mark Approval For Implantable Sacral Neurostimulator Benzinga

May 14, 2021

04:05PM EDT Axonics(r) Announces Closing of Public Stock Offering and Full Exercise of Underwriters' Option to Purchase Additional Stock Business Wire

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

06:10AM EDT Axonics Late Tuesday Announced 3.5M Share Offering Priced at $50/Share Benzinga

May 11, 2021

11:04PM EDT Axonics Prices Public Offering Of 3.50 Mln Shares At $50.00/shr RTTNews

10:55PM EDT Axonics(r) Announces Upsize and Pricing of Public Offering of Common Stock Business Wire

04:19PM EDT Axonics Reports $150M Common Stock Offering Benzinga

04:17PM EDT Axonics(r) Announces Proposed Public Offering of Common Stock Business Wire

May 7, 2021

07:52AM EDT Morgan Stanley Maintains Overweight on Axonics, Raises Price Target to $62 Benzinga

06:47AM EDT Needham Maintains Buy on Axonics, Raises Price Target to $72 Benzinga

May 6, 2021

04:12PM EDT Axonics Modulation Tech Sees FY21 Sales $176M-$180M Vs. $169.92M Est. Benzinga

04:11PM EDT Axonics Modulation Tech Q1 EPS $(0.57) Misses $(0.41) Estimate, Sales $34.40M Beat $27.88M Estimate Benzinga

04:01PM EDT Axonics(r) Reports First Quarter 2021 Financial Results Business Wire

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 30, 2021

07:31AM EDT The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs Benzinga

Apr 29, 2021

08:15AM EDT The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx Benzinga

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

08:09AM EDT The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs Benzinga

06:00AM EDT Axonics(r) to Participate in the BofA Securities 2021 Virtual Healthcare Conference Business Wire

Apr 1, 2021

07:46AM EDT The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract Benzinga

Mar 24, 2021

06:43AM EDT Needham Maintains Buy on Axonics Modulation Tech, Raises Price Target to $71 Benzinga

Mar 16, 2021

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

Mar 12, 2021

07:36AM EST The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs Benzinga

Mar 10, 2021

07:26AM EST The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link Benzinga

Mar 9, 2021

09:17AM EST The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data Benzinga

Mar 2, 2021

07:57AM EST Endotronix Appoints Dan Dearen To Board RTTNews

07:55AM EST Endotronix Appoints Industry Veteran Dan Dearen to Board of Directors PR Newswire

06:13AM EST Axonics Announces Alliance With Micro Systems Technologies; Says 'The newly developed Axonics non-rechargeable implantable neurostimulator will be manufactured on the most advanced printed circuit board assembly line at Micro Systems Engineering; Benzinga

Feb 26, 2021

08:37AM EST Axonics Acquires Urethral Bulking Agent For $200M Benzinga

06:26AM EST Needham Maintains Buy on Axonics Modulation Tech, Raises Price Target to $66 Benzinga

Feb 25, 2021

04:43PM EST Axonics Modulation Tech Q4 Net Loss $11.3M vs $22.8M In Same Qtr. Last Year, Sales $34.80M Miss $35.11M Estimate Benzinga

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 24, 2021

10:07AM EST Axonics Modulation Tech Earnings Preview Benzinga

Feb 16, 2021

06:09AM EST Axonics Receives FDA Approval For Third-Generation Implantable Neurostimulator Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 25, 2021

04:03PM EST Axonics Sees Q4 2020 Net Revs. $34.7M-$34.9M Vs Est $34.1M-$37.2M Benzinga

Jan 22, 2021

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 7, 2021

11:00AM EST Morgan Stanley Maintains Overweight on Axonics Modulation Tech, Raises Price Target to $58 Benzinga

Nov 5, 2020

09:29AM EST Piper Sandler Maintains Overweight on Axonics Modulation Tech, Raises Price Target to $57 Benzinga

06:36AM EST Needham Maintains Buy on Axonics Modulation Tech, Raises Price Target to $62 Benzinga

Nov 4, 2020

04:01PM EST Axonics Modulation Tech Q3 EPS $(0.24) Beats $(0.50) Estimate, Sales $35.20M Beat $22.95M Estimate Benzinga

08:21AM EST The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings Benzinga

04:41AM EST Earnings Scheduled For November 4, 2020 Benzinga

Nov 1, 2020

09:40AM EST The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings Benzinga

Oct 29, 2020

06:38AM EDT Axonics Submits PMA Supplement To FDA To Further Expand MRI Labeling Benzinga

Oct 23, 2020

10:48AM EDT Benzinga's Top Upgrades, Downgrades For October 23, 2020 Benzinga

06:04AM EDT Guggenheim Initiates Coverage On Axonics Modulation Tech with Buy Rating, Announces Price Target of $77 Benzinga

Oct 20, 2020

08:09AM EDT Axonics Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System Benzinga

Oct 14, 2020

10:25AM EDT Axonics Modulation Tech Option Alert: Nov 20 $50 Calls at the Ask: 739 @ $2.9 vs 3312 OI; Earnings 11/12 After Close [est] Ref=$46.89 Benzinga

Oct 12, 2020

10:19AM EDT SVB Leerink Maintains Outperform on Axonics Modulation Tech, Raises Price Target to $60 Benzinga

Sep 23, 2020

07:00AM EDT - Longitude Venture Partners IV will build on the Firms commitment to improve clinical outcomes, enhance patient quality of life, and drive efficiency in healthcare delivery - GlobeNewswire Inc

Sep 21, 2020

06:01AM EDT Axonics Receives Health Canada Approval of Implantable Neurostimulator Benzinga

Sep 10, 2020

06:06AM EDT Axonics Modulation Technologies Reports Its 2-Year Clinical Results From Its ARTUSAN-SNM Pivotal Study Which Shows A 88% Responders Rate In All Implanted Participants Benzinga

Sep 8, 2020

08:38AM EDT Axonics Announces NICE Recommends Axonics r-SNM System For Treating Overactive Bladder Benzinga

08:34AM EDT NICE Recommends Axonics R-SNM System For Treating Overactive Bladder RTTNews

Sep 3, 2020

06:00AM EDT Axonics(r) to Participate in Upcoming Investor Conferences Business Wire

Sep 2, 2020

10:01AM EDT Axonics To Host Presentation Of Full 2-Year Clinical Results From ARTISAN-SNM Pivotal Study On Sept. 9 Benzinga

10:00AM EDT Axonics(r) to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9 Business Wire

06:14AM EDT Baird Initiates Coverage On Axonics Modulation Tech with Outperform Rating, Announces Price Target of $52 Benzinga

Aug 10, 2020

08:32AM EDT Morgan Stanley Maintains Overweight on Axonics Modulation Tech, Raises Price Target to $53 Benzinga

Aug 7, 2020

08:58AM EDT SVB Leerink Maintains Outperform on Axonics Modulation Tech, Raises Price Target to $59 Benzinga

05:44AM EDT Needham Maintains Buy on Axonics Modulation Tech, Raises Price Target to $57 Benzinga

Aug 6, 2020

04:01PM EDT Axonics Modulation Tech Q2 EPS $(0.54) Beats $(0.67) Estimate, Sales $15.20M Beat $5.19M Estimate Benzinga

04:00PM EDT Axonics(r) Reports Second Quarter 2020 Results Business Wire

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Jul 27, 2020

06:04AM EDT Axonics Announces 2-Year Topline Clinical Results From ARTISAN-SNM Pivotal Study RTTNews

06:04AM EDT Axonics Announces 2-Yr Topline Clinical Results From ARTISAN-SNM Pivotal Study Demonstrate Patients Implanted With r-SNM System Continue to Receive Clinically Meaningful and Statistically Significant Improvements in Urinary Urgency Incontinence Symptoms and Quality of Life Benzinga

06:00AM EDT Axonics(r) Announces 2-Year Topline Clinical Results from ARTISAN-SNM Pivotal Study Business Wire

Jul 22, 2020

06:42AM EDT SVB Leerink Maintains Outperform on Axonics Modulation Tech, Raises Price Target to $48 Benzinga

Jul 16, 2020

06:00AM EDT Axonics(r) to Report Second Quarter 2020 Results on August 6 Business Wire

Jul 13, 2020

06:14AM EDT Axonics Modulation Tech Sees Q2 Sales $15.200M vs $5.19M Est Benzinga

06:08AM EDT Axonicsn Sees Q2 Preliminary Net Revenue To Be $15.2 Mln RTTNews

06:00AM EDT Axonics(r) Reports Preliminary Second Quarter 2020 Revenue Business Wire

Share